مشخصات مقاله | |
ترجمه عنوان مقاله | عفونت COVID-19: منشاء، انتقال و ویژگی های کروناویروس انسانی |
عنوان انگلیسی مقاله | COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses |
انتشار | مقاله سال ۲۰۲۰ |
تعداد صفحات مقاله انگلیسی | ۸ صفحه |
هزینه | دانلود مقاله انگلیسی رایگان میباشد. |
پایگاه داده | نشریه الزویر |
نوع نگارش مقاله |
مقاله مروری (Review Article) |
مقاله بیس | این مقاله بیس نمیباشد |
نمایه (index) | Scopus – Master Journals List – JCR |
نوع مقاله | ISI |
فرمت مقاله انگلیسی | |
ایمپکت فاکتور(IF) |
۵٫۴۶۰ در سال ۲۰۱۹ |
شاخص H_index | ۳۶ در سال ۲۰۲۰ |
شاخص SJR | ۱٫۰۹۷ در سال ۲۰۱۹ |
شناسه ISSN | ۲۰۹۰-۱۲۳۲ |
شاخص Quartile (چارک) | Q1 در سال ۲۰۱۹ |
مدل مفهومی | ندارد |
پرسشنامه | ندارد |
متغیر | ندارد |
رفرنس | دارد |
رشته های مرتبط | پزشکی |
گرایش های مرتبط | ویروس شناسی پزشکی، بیمار های عفونی، ژنتیک پزشکی، اپیدمیولوژی یا همه گیر شناسی، ایمنی شناسی پزشکی یا ایمونولوژی، پزشکی مولکولی |
نوع ارائه مقاله |
ژورنال |
مجله | مجله تحقیقات پیشرفته – Journal of Advanced Research |
دانشگاه | The Department of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, PR China |
کلمات کلیدی | کروناویروس، کووید ۱۹، منشاء، شیوع، گسترش |
کلمات کلیدی انگلیسی | Coronaviruses، COVID-19، Origin، Outbreak، Spread |
شناسه دیجیتال – doi |
https://doi.org/10.1016/j.jare.2020.03.005 |
کد محصول | E14859 |
وضعیت ترجمه مقاله | ترجمه آماده این مقاله موجود نمیباشد. میتوانید از طریق دکمه پایین سفارش دهید. |
دانلود رایگان مقاله | دانلود رایگان مقاله انگلیسی |
سفارش ترجمه این مقاله | سفارش ترجمه این مقاله |
فهرست مطالب مقاله: |
Abstract Graphical abstract Introduction Comparative analysis of emergence and spreading of coronaviruses Primary reservoirs and hosts of coronaviruses Key features and entry mechanism of human coronaviruses Genomic variations in SARS-CoV-2 The major obstacle in research progress Potential therapeutic strategies against COVID-19 Vaccines for SARS-CoV-2 Conclusion and perspective Acknowledgments Declaration of Competing Interest References |
بخشی از متن مقاله: |
Abstract
The coronavirus disease 19 (COVID-19) is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in Wuhan, China and spread around the world. Genomic analysis revealed that SARS-CoV-2 is phylogenetically related to severe acute respiratory syndrome-like (SARS-like) bat viruses, therefore bats could be the possible primary reservoir. The intermediate source of origin and transfer to humans is not known, however, the rapid human to human transfer has been confirmed widely. There is no clinically approved antiviral drug or vaccine available to be used against COVID-19. However, few broad-spectrum antiviral drugs have been evaluated against COVID-19 in clinical trials, resulted in clinical recovery. In the current review, we summarize and comparatively analyze the emergence and pathogenicity of COVID-19 infection and previous human coronaviruses severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV). We also discuss the approaches for developing effective vaccines and therapeutic combinations to cope with this viral outbreak. Introduction Coronaviruses belong to the Coronaviridae family in the Nidovirales order. Corona represents crown-like spikes on the outer surface of the virus; thus, it was named as a coronavirus. Coronaviruses are minute in size (65–۱۲۵ nm in diameter) and contain a single-stranded RNA as a nucleic material, size ranging from 26 to 32kbs in length (Fig. 1). The subgroups of coronaviruses family are alpha (a), beta (b), gamma (c) and delta (d) coronavirus. The severe acute respiratory syndrome coronavirus (SARS-CoV), H5N1 influenza A, H1N1 2009 and Middle East respiratory syndrome coronavirus (MERS-CoV) cause acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) which leads to pulmonary failure and result in fatality. These viruses were thought to infect only animals until the world witnessed a severe acute respiratory syndrome (SARS) outbreak caused by SARS-CoV, 2002 in Guangdong, China [1]. Only a decade later, another pathogenic coronavirus, known as Middle East respiratory syndrome coronavirus (MERS-CoV) caused an endemic in Middle Eastern countries [2]. ]. Recently at the end of 2019, Wuhan an emerging business hub of China experienced an outbreak of a novel coronavirus that killed more than eighteen hundred and infected over seventy thousand individuals within the first fifty days of the epidemic. This virus was reported to be a member of the b group of coronaviruses. The novel virus was named as Wuhan coronavirus or 2019 novel coronavirus (2019-nCov) by the Chinese researchers. The International Committee on Taxonomy of Viruses (ICTV) named the virus as SARS-CoV-2 and the disease as COVID-19 [3–۵]. In the history, SRAS-CoV (2003) infected 8098 individuals with mortality rate of 9%, across 26 contries in the world, on the other hand, novel corona virus (2019) infected 120,000 induviduals with mortality rate of 2.9%, across 109 countries, till date of this writing. |